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Abstract The 70-kDa TNF cell surface receptor (p70TNFR) 
and the related 75-kDa nerve growth factor (NGF) receptor 
(p75NGFR) can enhance cell death. Expression of p70TNFR or 
p75NGFR in HeLa cells resulted in enhanced TNF-induced apop- 
totic cell death with a corresponding elevation of cytosolic phos- 
pholipase A2 (cPLA2) levels. This response was apparent by 
24 h, did not occur with NGF treatment or when vector or TrkA 
NGFR were expressed and was reversed by dexamethasone pre- 
treatment. These findings reveal a novel mechanism by which the 
p70TNFR and p75NGFR achieve enhanced TNFR-mediated 
programmed cell death by elevating cPLA z levels. 
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I. Introduction 
Tumour necrosis factor alpha (TNF), a cytokine secreted 
primarily by activated macrophages and monocytes, has a wide 
range of biological involvements, uch as in inflammatory re- 
sponses, antitumour activity, enhancement of cell growth and 
selective cellular cytotoxicity [1]. Two high-affinity TNF recep- 
tor subtypes have been cloned, representing single transmem- 
brahe domain glycoproteins of molecular masses 55-60 
(p55TNFR) and 70-80 (p70TNFR) kDa. Both these receptors 
have significant extracellular domain homology, however, their 
cytoplasmic domains are unrelated, contain no sequences with 
recognisable catalytic apabilities and give no indication as to 
the signalling processes by which these receptors may act [2]. 
In its cytoplasmic domain, the p75 nerve growth factor (NGF) 
receptor (p75NGFR) has sequence homology to the p70TNFR 
cytoplasmic domain [3-8]. All of these receptors have been 
reported to influence cell death [9-13], although the exact cellu- 
lar signalling mechanisms by which these receptors achieve 
their effects are poorly understood. 
Arachidonic acid is the precursor in the biosynthesis of both 
prostaglandins and leukotrienes [14,15] and cytosolic phospho- 
lipase A2 (cPLA2) is a 100-kDa enzyme that selectively utilises 
phospholipid substrates containing arachidonic acid in the sn-2 
position. Agonists, such as thrombin, platelet-derived growth 
factor, epidermal growth factor and ATP [16-18], plus the 
serine kinases protein kinase C (PKC) and mitogen-activated 
protein (MAP) kinase, were shown to phosphorylate and acti- 
vate cPLA z [19,20]. Furthermore, it has been shown that cyto- 
kines, macrophage colony-stimulating factor can influence 
cPLA2 activity [21-23]. Cytokines, such as interleukin-lfl and 
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TNF, increase the activity of cPLA 2 by phosphorylation a d 
induce the synthesis of new cPLA2 protein. Such profound 
effects of TNF on cPLA2 suggests a possible role for the it in 
TNF actions, such as apoptosis. Indeed, it was shown that 
cPLA2 is critical in the cytotoxic action of TNF [24] and that 
lipoxygenase metabolites of arachidonic acid were mediating 
TNF-induced cell death. Furthermore, oxygen radicals which 
are generated by the peroxidation of arachidonic acid meta- 
bolites, are thought o be involved in TNF-induced cytotoxicity 
[25] and the cytotoxic actions of these radicals can be reversed 
by the oxygen radical-scavenging enzymes, manganous super- 
oxide dismutase and bcl-2 [26,27]. 
We undertook investigations to reveal the influence of cPLA 2 
in TNF-induced cytotoxicity using the HeLa cell model of 
TNF-induced cytotoxicity (a cell line reported to contain 
p55TNFR with little endogenous p70TNFR content [10]) and 




Recombinant human TNF was purchased from R&D Systems. 
Human NGF and TrkA riboprobe vector were kindly provided by 
E.M. Shooter (Stanford University, Palo Alto, CA). Polyclonal anti- 
ePLA2 antiserum and cPLA 2 cDNA was generated by the Genetics 
Institute (Boston, MA). [3H]AA ([5,6,8,9,11,12,14,15-3H(N)]ara - 
chidonic acid, specific activity = 100 Ci/mmol) was purchased from 
NEN/DuPont. 
2.2. HeLa cell transfections 
Stable transfections of HeLa cells with receptor cDNAs were per- 
formed in a Bio-Rad Gene Pulser electroporator (960/2FD, 0.25 V). 50 
pg of the full-length receptor cDNAs in the pCDM8 mammalian ex- 
pression vector (Invitrogen) were cotransfected with the pSV2 plasmid 
carrying the hygromycin phosphotransferase gene, mixed with 350/.tg 
of yeast RNA acting as carrier in 20 mM HEPES (pH 7.4). HeLa 
clones were cultured as described [10]. Hygromycin-resistant colonies 
were selected in growth medium supplemented with 400 flg/ml hygro- 
mycin (Boehringer Mannheim) and maintained at200/~g/ml hygromy- 
cin. Positive clones were identified by a combination ofWestern analy- 
sis and [t25I]TNF or -NGF ligand-binding studies [28]. 
2.3. Northern analysis" 
Total RNA was isolated by extraction with guanidine thiocyanate 
then centrifugation on a CsC1 gradient as described [7]. Glyoxal-dena- 
tured RNA was electrophoresed and transferred to positively charged 
Nytran (Schleicher and Schuell). Full-length cDNA probes were 
[32P]dCTP-labelled by random prime reaction (Gibco BRL kit) and 
hybridized to the blots overnight at 42°C in hybridization solution (50% 
formamide, 5× Denhardt's, 0.5% sodium dodecylsulphate (SDS), 100 
/lg/ml tRNA, 200 Jlg/ml salmon sperm DNA and 5 × SSPE), then 
washed (3 × 20 min in 0.1 × SSPE, 0.2% SDS, 50°C) before autoradi- 
ographic exposure at -80°C with intensifying screens. 
2.4. Western analysis 
Cell monolayers were directly lysed with 2% SDS, 70 mM Tris-HCl 
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A (pH 6.8), then boiled for 15 min to denature proteins and nucleic acids. Whole cell sample protein concentrations were determined (Pierce 
assay kit) then supplemented with 6 × loading buffer (60% glycerol, 
12.5% fl-mercaptoethanol, 1% bromophenyl b ue). Samples were boiled 
for a further 3 min before loading equal amounts of total protein 
followed by SDS/PAGE. Electrophoresed proteins were electrically 
transferred to a Millipore Imobilon-P membrane and blocked with 
Ca2+/Mg+-free PBS + 5% non-fat dried milk, 0.5% Tween-20. Anti- 
body-binding to the blot (1-2 h, 25°C, in blocking solution) was fol- 
lowed by washing (3 × 5 min) then a 30 min incubation with protein 
A-horseradish peroxidase (1:10,000) (Calbiochem). After further 
washing (3 × 5 min), specific protein-antibody interactions were de- 
tected with ECL detection agents (Amersham). 
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2.5. Cytotoxicity assay 
Freshly dispersed cells were aliquoted into 96-well culture plates 
(Costar) at a cell density of 1 × 105 cells/ml (100 ~tl of cell suspension/ 
well). After 24 h growth, the plates were treated with the required 
combination of agents and incubated for a further 24 h. Colourimetric 
determination f the attached cell number in each well was performed 
as described [10]. 
2.6. Arachidonic acid release studies 
Confluent HeLa cells in Costar 12-well culture plates were isotopi- 
cally labelled for 2-4 h in growth medium with 0.5/~Ci/ml [3H]ara- 
chidonic acid. After labelling, wells were washed once with 1 ml of 
Opti-MEM (Gibco-BRL) and incubated with Opti-MEM with or with- 
out the desired concentration of cytokine. At the required time, the 
medium from the well was centrifuged (16,000 x g, 3 min, 4°C) to pellet 
any detached cells, then its radioactivity determined which measures the 
[3H]AA (or its radioactive metabolites) liberation from labelled phos- 
pholipid pools. 
2. 7. Apoptosis assay 
Cells were incubated in growth medium supplemented with various 
agents for 15 h before confluent cells were detached by incubation with 
Ca2*/Mg+-free PBS+0.5 mM EDTA (37°C). Both adherent and non- 
adherent cells were pooled, washed once in growth medium (4°C) and 
DNA was stained by inclusion of 5/2g/ml Hoechst 33342 stain. A 5-/21 
aliquot of the stained cell sample was examined by epifluorescence 
using a Leitz Aristoplan microscope quipped with an A cube and 
photographed at 320 x magnification. Fields with large numbers of 
cells were use to ascertain the % of the cells which were intensely 
fluorescing under ultraviolet excitation due to chromosomal compac- 
tion and nuclear karyorrhexis (an indication of apoptotic mechanisms 
of cell death). The existence of non-fluorescent cells was confirmed by 
visible light microscopy. 
3. Results 
As has been previously reported [23] and can be seen from 
Fig. 1, TNF  (50 ng/ml for 4 and 8 h) induced cPLA2 mRNA 
Table 1 
Enhanced TNF-induced HeLa cell death occurs through apoptotic 
mechanisms 
HeLa clone TNF~-induced apoptotic ells 
(% of total cells, mean + S.D.) 
Wild-type 26.1 + 10.0 
p75NGFR 66.1 + 10.4 
p70TNFR (#1) 59.2 + 10.5 
p70TNFR (#2) 78.1 + 9.4 
TrkA 31.3 + 6.9 
Hygromycin-resistant 17.8 + 8.5 
Cells were incubated in growth medium supplemented with 50 ng/ml 
TNF for 15 h before confluent cells were detached by incubation with 
Ca2*/Mg*-free PBS plus 0.5 mM EDTA (37°C). Both adherent and 
non-adherent cells were pooled, washed once by resuspension-centrifu- 
gation in growth medium (4°C), DNA was stained and cells were 
analysed as described in section 2. Approximately 4% of unstimulated 
cells appeared apoptotic. 
B 
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Fig. 1. Basal and TNF-induced levels of cPLA 2 mRNA and protein are 
greater in p75NGFR- and p70TNFR-expressing HeLa cells. Panel A: 
autoradiograms of cPLA2 and fl-actin mRNAs from wild-type, 
p75NGFR-overexpressing and p70TNFR-overexpressing HeLa cells 
treated with 50 ng/ml recombinant human TNF for the indicated times. 
Total RNA (15/2g/lane) was analysed for expression of the 3.4 kb 
cPLA2 and 1.5 kb fl-actin mRNAs using specific 32P-labelled cDNA 
probes. Autoradiographic exposure was at -80°C with intensifying 
screens for 24 and 4 h, respectively. Panel B: same as in panel A, except 
cells were treated with 100 ng/ml human NGF. Panel C: Western 
analysis of cPLA 2 protein levels in wild-type, p75NGFR-overex- 
pressing and p70TNFR-overexpressing HeLa cells treated with 50 ng/ 
ml TNF for the indicated times. 50/tg protein/lane was electrophoresed 
on an 8% SDS gels. By comparison, the extreme most right lane con- 
tains 10/tg of total protein from a Chinese hamster ovary (CHO) cell 
line which is stably overexpressing cPLA 2 as a standard. Specific poly- 
clonal cPLA2 antibody (1:1000 dilution) binding was visualized by 
enhanced chemiluminescence by a 15-s exposure. The results in Fig. 1 
are typical data from at least 4 independent experiments. 
levels in HeLa cells. Treatment with 100 ng/ml NGF had no 
effect on cPLA 2 mRNA levels (Fig. lb). Interestingly, the basal 
levels o fcPLA 2 mRNA were higher in both the p75NGFR-  and 
p70TNFR-stably  overexpressing HeLa clones. In spite of 
raised basal levels of cPLA2 mRNA in p75NGFR and 
p70TNFR clones, TNF  still increased the message levels in a 
t ime-dependent manner  (Fig. la), again confirmed by cPLA2 
Western analysis (Fig. lc). TNF  treatment resulted in a time- 
dependent (0-18 h) increase in cPLA2 protein levels in wild-type 
and p70TNFR-and p75NGFR-expressing cells. Moreover, 
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Enhanced TNF-induced cytotoxicity in p75NGFR- and Fig. 2. 
p70TNFR-expressing HeLa cells. Concentration-response curves for 
TNF were determined in the absence (open symbols) or additional 
presence (closed symbols) of 100 ng/ml NGF for wild-type (circles), 
p75NGFR-overexpressing (squares) and p70TNFR-overexpressing 
(triangles) HeLa cells. Levels of TNF-induced cell death were deter- 
mined as described in section 2. The data represents he mean of at least 
8 treatment wells, from at least 3 independent experiments. S.D. values 
were < 5%. 
basal cPLA2 levels were higher in the p75NGFR- and 
p70TNFR-overexpressing HeLa cells, resulting (by 8-18 h 
TNF treatment, times at which cell death is occurring) in mark- 
edly greater levels of cPLA2 in the overexpressing cells, as 
compared with the wild-type HeLa. These finding are of inter- 
est such that both the p70TNFR and p75NGFR cells were 
found to be much more susceptible to TNF-induced cytotox- 
icity as compared with wild-type HeLa cells. 
Fig. 2 displays the TNF cytotoxicity concentration-response 
curves for wild-type and p75NGFR- or p70TNFR-overex- 
pressing HeLa cells. TNF caused a concentration-dependent 
cytotoxic response in all three clones, however, TNF far more 
potently killed the p70TNFR- and p75NGFR-overexpressing 
cells (maximal typical cytotoxic response of 75-95% death) 
than wild-type HeLa cells (typically, only 20-30% death). It is 
noteworthy that the cytotoxic responses een here are: for a 
period of only 24 h in the presence of cytokine (times of up to 
72 h can be routinely used by others); and also in the absence 
of any cyclohexamide, an agent used by others (in addition to 
TNF) permissively to 'reveal' any cytotoxic action of TNF [29]. 
Thus, our system demonstrates acute cytotoxic responses to 
TNF. 
To assess whether the enhanced cytotoxic actions of TNF are 
affected by the raised levels of cPLA 2 in the p70TNFR- and 
p75NGFR-overexpressing cells, we generated several more sta- 
bly expressing HeLa clones for our investigations. The 
p75NGFR and TrkA receptors both bind NGF, however, they 
are both sequentially and functionally distinct in that the TrkA 
receptor contains an intrinsic tyrosine kinase [30]. TrkA and 
hygromycin-resistant HeLa cells were similar to wild-type 
HeLa cells in that they displayed both low basal cPLA2 levels 
and low susceptibility to TNF-induced cytotoxicity (Fig. 3). 
Thus, the raised cPLA z levels and enhanced eath is specific to 
HeLa cells expressing either the p70TNFR or the p75NGFR 
and not due purely to expression of a cell surface NGF recep- 
tor, or of exerting hygromycin resistance upon the cells. 
Using the Hoechst staining method of determining condensa- 
tion of nuclear chromatin (an indication of apoptotic mecha- 
nisms of death), we determined that the HeLa cells were indeed 
dying from apoptotic, rather than necrotic mechanisms. Apop- 
totic mechanisms of cell death were also confirmed by the 
detection of nuclear DNA 'laddering' in TNF-treated HeLa 
cells (data not shown). Table 1 illustrates that the greater TNF- 
induced apoptosis in p70TNFR- or p75NGFR-expressing 
HeLa cells is clone-specific. This enhanced apoptosis was not 
observed in wild-type, TrkA-expressing or hygromycin-re- 
sistant cells treated with TNF. Furthermore, another independ- 
ently derived p70TNFR-overexpressing HeLa clone 
(p70TNFR (#2)) showed similar results in these studies (see 
Table 1) as the original p70TNFR-overexpressing clone. 
The [3H]arachidonic acid release assay was used as a func- 
tional display ofcPLA2 activity in HeLa clones. As seen in Fig. 
4, once again the HeLa clones which displayed significantly 
greater TNF-induced apoptosis (the p70TNFR and 
p75NGFR-expressing clones) than clones which displayed only 
minimal TNF-induced death (wild-type, TrkA and hygromy- 
cin-resistant clones), had markedly greater TNF-induced 
cPLA 2 activity. This clonal difference was manifested as greater 
induction of cellular cPLA 2 activity by TNF treatments of 6 h 
or longer (similar to the cPLA2 mRNA and protein induction 
time course in Fig. 1). Although it appears that the initial 
transient liberation of [3H]arachidonic a id is of a similar mag- 
nitude in all the clones tested, it is the secondary, longer-term 
increase in [3H]arachidonic acid liberation (corresponding to
cPLA2 mRNA induction) that separates the clones into those 
which are susceptible or are relatively resistant to TNF-induced 
death. As cell death occurs at times of 8 h TNF treatment or 
greater, it is probable that it is the TNF-stimulated cPLA2 gene 
expression which is critical for mediating apoptosis in HeLa 
cells. 
Pretreatment of p70TNFR- and p75NGFR-overexpressing 
and wild-type HeLa cells for periods of up to 24 h with 1/IM 
dexamethasone, r versed TNF-induced cytotoxicity. This re- 
duction of TNF-induced cell death was matched by a reduction 
in cPLA2 protein levels in all three clones (data not shown). As 
was reported previously [23], dexamethasone could specifically 
block the induced synthesis of cPLA 2 by TNF treatment and 
it appears here that it can reduce the elevated cPLA 2 levels in 
p70TNFR- and p75NGFR-expressing cells to those levels seen 
in wild-type HeLa cells. This consistent observation of elevated 
cPLA2 levels is apparently a prerequisite for observing en- 
hanced TNF-induced eath in HeLa cells. Evidence in support 
of a role for PLA 2 in TNF-induced death was reported in 
WEHI-S cells, where expression of a 70-kDa major heat-shock 
protein inhibits TNF-induced cytotoxicity. This heat-shock 
protein acts to inhibit TNF-induced PLA 2 activity [31]. Previ- 
ously, Hayakawa et al. [24] observed that TNF-induced cyto- 
toxicity in L929 cells was utterly dependent on the presence of 
cPLA 2 in those cells. 
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Fig. 3. Compared with wild-type cells, TNF-induced cytotoxicity and 
cPLA2 levels are similar in TrkA-expressing and hygromycin-resistant 
HeLa cells. Panel A: concentration-response curves for TNF-induced 
cell death were determined inthe absence (open symbols) or additional 
presence (closed symbols) of 100 ng/ml NGF for wild-type (circles), 
TrkA-overexpressing (squares) and hygromycin-resistant (triangles) 
HeLa cells. The data represents he mean of at least 8 treatment wells, 
from at least 2 independent experiments. S.D. values were < 5%. Panel 
B: autoradiogram of cPLA 2 mRNA levels from wild-type, TrkA-over- 
expressing and hygromycin-resistant HeLa cells treated for 0 or 8 h with 
50 ng/ml TNF. Total RNA (15 ,ug/lane) was probed with 32P-labelled 
cPLA2 eDNA probe and then exposed at -80°C for 4 days with inten- 
sifying screens. 
4. Discussion 
The ability of the two TNF receptors to signal independently 
for cytotoxicity is presently a controversial topic. It has been 
claimed that the p55TNFR exclusively signals to induce cell 
death [29]. Further work by Tartaglia et al. demonstrated a 
region within the intracellular domain ofp55TNFR (termed the 
'death domain') which is crucial for cytotoxicity [32]. Thus, the 
ability of the p55TNFR to signal for cell death remains con- 
vincing. However, the influence that the p70TNFR has on cell 
death is presently unresolved. 
Previous reports provided evidence for a role for the 
p70TNFR in enhancing TNF-induced cytotoxicity [9,33,34]. 
Other reports suggested that p70TNFR could cause apoptosis 
independently of p55TNFR activation [35,36]. It may be that 
the function of the p70TNFR in apoptosis is to enhance 
p55TNFR-mediated actions. Such a functional role has already 
been suggested for the p70TNFR by Tartaglia et al. [11]. In this 
model, the receptor serves to present ligand to another eceptor 
(p55TNFR), which in turn signals for cell death. The enhance- 
ments of cytotoxicity by the p70TNFR would be a result of 
increased local TNF concentration around the p55TNFR. 
Such a 'ligand passing' model of the p70TNFR and p75NGFR 
could be consistent with the data presented here. However, the 
presence of the p75NGFR receptor (which does not bind TNF) 
was sufficient to enhance TNF-induced apoptosis in HeLa 
cells, but expression of any of the other receptors used in this 
study did not result in enhanced apoptosis. These data with the 
permissive role of either the p70TNFR or p75NGFR suggests 
that these receptors specifically introduce into the cell, a mech- 
anism by which TNF-mediated cell death can be enhanced. 
This mechanism ay be the increase in basal levels of cPLA2, 
an enzyme clearly involved in TNF-induced apoptosis. Thus, 
we propose a model by which the p70TNFR (and p75NGFR) 
enhance programmed cell death: the presence of the receptor 
(not necessarily its ligand-mediated signal transducing activi- 
ties) induces production of an intracellular mediator(s) (includ- 
ing cPLA2 for the production of arachidonic acid metabolites) 
which is utilised by the TNF-stimulated signalling pathways of 
the p55TNFR. 
No direct signalling function has yet been attributed to the 
p70TNFR and p75NGFR cytoplasmic domains. These recep- 
tors may acquire other cytoplasmic entities to form fully active 
signalling complexes. Indeed, it is known that p55TNFRs must 
dimerize in order to activate its signalling pathways [1]. Indeed, 
the cytoplasmic domain of the p70TNFR was recently found 
to directly bind two TNF receptor-associated factors (TRAFs 
1 and 2) which were necessary for the receptor's ignal 
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Fig. 4. TNF-induced arachidonic acid release is greater in HeLa cells 
that display enhanced TNF-induced eath. Time courses of 50 ng/ml 
TNF induced [3H]arachidonic a id release from wild-type HeLa cells 
(open circles), TrkA-expressing (open squares), hygromycin-resistant 
(open triangles), p75NGFR-expressing (closed triangles) and two inde- 
pendently derived clones of HeLa cells expressing p70TNFR (closed 
circles and closed squares). The data represent the mean _+ S.E. of 3 
separate experiments. 
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transduction [37]. The signalling mechanisms utilised by these 
TRAFs was not determined, however, the p75NGFR was also 
recently found to couple to sphingomyelin turnover [38]. The 
sphingomyelin pathway was implicated in apoptosis [39] and it 
may be that this pathway is involved not only in p75NGFR but 
also p70TNFR enhancement of cell death. It is uncertain what 
precise role the enhancement of cPLA2 levels by the p70TNFR 
and p75NGFR has, but uncovers further pathway mechanisms 
by which these novel receptors may operate. 
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